Royal Bank of Canada Cuts Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Royal Bank of Canada trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 17.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,049,013 shares of the company's stock after selling 215,247 shares during the quarter. Royal Bank of Canada owned approximately 0.84% of Henry Schein worth $72,591,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC boosted its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares in the last quarter. Guggenheim Capital LLC lifted its position in Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after purchasing an additional 159 shares during the period. CIBC Asset Management Inc lifted its position in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after purchasing an additional 169 shares during the period. Metis Global Partners LLC lifted its position in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after purchasing an additional 187 shares during the period. Finally, Sanctuary Advisors LLC lifted its position in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock valued at $294,000 after purchasing an additional 203 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HSIC. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Barrington Research cut their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company dropped their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Finally, StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $73.13 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market capitalization of $8.90 billion, a price-to-earnings ratio of 30.09, a PEG ratio of 2.13 and a beta of 0.87. The company's 50-day moving average is $67.44 and its two-hundred day moving average is $71.49. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the business posted $1.10 EPS. The business's revenue for the quarter was down .1% compared to the same quarter last year. Analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.